A carregar...
Siplizumab selectively depletes effector memory T-cells and promotes a relative expansion of alloreactive regulatory T-cells in vitro
Siplizumab, a humanized anti-CD2 monoclonal antibody, has been used in conditioning regimens for hematopoietic cell transplantation and tolerance induction with combined kidney-bone marrow transplantation. Siplizumab-based tolerance induction regimens deplete T cells globally while enriching regulat...
Na minha lista:
| Publicado no: | Am J Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6940533/ https://ncbi.nlm.nih.gov/pubmed/31319439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15533 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|